Last reviewed 2026-04-22 · How we verify

FEMCON® Fe

FEMCON Fe is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of ethinyl estradiol and norethindrone, while the ferrous fumarate component replaces iron lost during menstruation.

FEMCON Fe is an oral contraceptive that prevents pregnancy by suppressing ovulation through a combination of ethinyl estradiol and norethindrone, while the ferrous fumarate component replaces iron lost during menstruation. Used for Contraception (prevention of pregnancy), Regulation of menstrual cycle.

At a glance

Mechanism of action

The hormonal components work by inhibiting the luteinizing hormone (LH) surge needed for ovulation and by thickening cervical mucus to impede sperm penetration. The ferrous fumarate (iron) supplement is included in the placebo pills to maintain iron levels during the menstrual cycle and reduce the risk of iron-deficiency anemia in women taking oral contraceptives.

Approved indications

• Contraception (prevention of pregnancy)
• Regulation of menstrual cycle

Common side effects

• Nausea
• Headache
• Breast tenderness
• Breakthrough bleeding
• Mood changes
• Venous thromboembolism

Key clinical trials

• Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Non-Fasted Conditions (PHASE1)
• Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.